Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine

Adenovirus vectored vaccines are a highly effective strategy to induce cellular immune responses which are particularly effective against intracellular pathogens. Recombinant simian adenovirus vectors were developed to circumvent the limitations imposed by the use of human adenoviruses due to widesp...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính:	Folegatti, P, Bellamy, D, Roberts, R, Powlson, J, Edwards, N, Mair, C, Bowyer, G, Poulton, I, Mitton, C, Green, N, Berrie, E, Lawrie, A, Hill, A, Ewer, K, Hermon-Taylor, J, Gilbert, S
Định dạng:	Journal article
Được phát hành:	MDPI 2019

Những quyển sách tương tự

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
Bằng: Pedro M. Folegatti, et al.
Được phát hành: (2019-05-01)

Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
Bằng: Zhang, C, et al.
Được phát hành: (2023)

CMV-associated T cell and NK cell terminal differentiation does not impact immunogenicity of ChAdOx1 vaccination
Bằng: Sharpe, HR, et al.
Được phát hành: (2022)

Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
Bằng: Cheng Zhang, et al.
Được phát hành: (2023-06-01)

Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
Bằng: Adam Berg, et al.
Được phát hành: (2021-10-01)

CMV-associated T cell and NK cell terminal differentiation does not affect immunogenicity of ChAdOx1 vaccination
Bằng: Hannah R. Sharpe, et al.
Được phát hành: (2022-03-01)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens
Bằng: Antrobus, R, et al.
Được phát hành: (2014)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens.
Bằng: Antrobus, R, et al.
Được phát hành: (2014)

Immunogenicity Differences of the ChAdOx1 nCoV-19 Vaccine According to Pre-Existing Adenovirus Immunity
Bằng: Jinnam Kim, et al.
Được phát hành: (2023-04-01)

Clinical assessment of ChAdOx1 vectored vaccines against emerging pathogens
Bằng: Moreira Folegatti, P
Được phát hành: (2021)

A single dose of ChAdOx1 Chik vaccine induces neutralising antibodies against four chikungunya virus lineages in a phase 1 clinical trial
Bằng: Folegatti, P, et al.
Được phát hành: (2021)

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.
Bằng: O'Hara, G, et al.
Được phát hành: (2012)

Combined intranasal and intramuscular parainfluenza 5-, simian adenovirus ChAdOx1- and poxvirus MVA-vectored vaccines induce synergistically HIV-1-specific T cells in the mucosa
Bằng: Ashley C. Beavis, et al.
Được phát hành: (2023-07-01)

Safety and immunogenicity of adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies
Bằng: Folegatti, P, et al.
Được phát hành: (2021)

Safety and immunogenicity of ChAdOx1 MERS Vaccine Candidate in Healthy Middle Eastern Adults: a dose-escalation, open-label, non-randomised, phase 1b trial
Bằng: Bosaeed, M, et al.
Được phát hành: (2021)

Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBV
Bằng: Charlotte Davis, et al.
Được phát hành: (2024-06-01)

A single dose of ChAdOx1 Chik vaccine induces neutralizing antibodies against four chikungunya virus lineages in a phase 1 clinical trial
Bằng: Pedro M. Folegatti, et al.
Được phát hành: (2021-07-01)

Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice
Bằng: Dicks, M, et al.
Được phát hành: (2015)

Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-Cell Vaccine
Bằng: Edmund G.-T. Wee, et al.
Được phát hành: (2024-08-01)

Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies
Bằng: Pedro M. Folegatti, et al.
Được phát hành: (2021-03-01)

Humoral immunogenicity and efficacy of a single dose of ChAdOx1 MERS vaccine candidate in dromedary camels
Bằng: Alharbi, N, et al.
Được phát hành: (2019)

Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan
Bằng: Jer-Hwa Chang, et al.
Được phát hành: (2022-02-01)

Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2
Bằng: Hermosilla, E, et al.
Được phát hành: (2022)

Safety and immunogenicity of a replication deficient simian adenoviral vectored chikungunya vaccine: A phase I, first-in-human, dose escalation trial
Bằng: Folegatti, PM, et al.
Được phát hành: (2019)

Association of Reactogenicity with Immunogenicity of the ChAdOx1 nCoV-19 Vaccine in Patients Undergoing Hemodialysis
Bằng: Ting-Yun Lin, et al.
Được phát hành: (2022-08-01)

HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV
Bằng: Tamsin Cargill, et al.
Được phát hành: (2023-11-01)

Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population
Bằng: Nawamin Pinpathomrat, et al.
Được phát hành: (2022-05-01)

Durability of ChAdOx1 nCov-19 vaccination in people living with HIV
Bằng: Ogbe, A, et al.
Được phát hành: (2022)

Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2
Bằng: Eduardo Hermosilla, et al.
Được phát hành: (2022-03-01)

Immunogenicity and efficacy of Zika virus envelope domain III in DNA, protein, and ChAdOx1 adenoviral-vectored vaccines
Bằng: López-Camacho, C, et al.
Được phát hành: (2020)

Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored Vaccines
Bằng: César López-Camacho, et al.
Được phát hành: (2020-06-01)

Is the ChAdOx1 Vaccine Safe and Immunogenic as Prophylactic Measure Against the Lethal Human-Coronaviruses? A Systematic Review
Bằng: Andréia Michelle Alves Cunha de Alcântar, et al.
Được phát hành: (2023-07-01)

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
Bằng: Ane Ogbe, et al.
Được phát hành: (2022-04-01)

Impact of ChAdOx1 or DNA Prime Vaccination on Magnitude, Breadth, and Focus of MVA-Boosted Immunogen-Specific T Cell Responses
Bằng: Alex Olvera, et al.
Được phát hành: (2024-03-01)

Author Correction: Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population
Bằng: Nawamin Pinpathomrat, et al.
Được phát hành: (2022-09-01)

Safety and immunogenicity of CoronaVac and ChAdOx1 heterologous prime-boost vaccines in an overweight population in Chiang Mai, Thailand
Bằng: Kriangkrai Chawansuntati, et al.
Được phát hành: (2024-06-01)

Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured onthe AGE1.CR.pIX Avian Cell Line
Bằng: Folegatti, P, et al.
Được phát hành: (2019)

Simian adenoviruses as vaccine vectors
Bằng: Morris, S, et al.
Được phát hành: (2016)

Simian adenoviruses as vaccine vectors
Bằng: Morris, S, et al.
Được phát hành: (2016)

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Bằng: Folegatti, PM, et al.
Được phát hành: (2020)